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Introduction 
 
Changes in the application of global quotas and other WTO inspired market liberalization 
measures in the textiles and clothing trade over the past decade have resulted in major 
restructuring of textile manufacturing in many countries. These countries have had to face the 
fact that they must become more competitive and more innovative in future in order to 
survive. This in turn has led to an increasing emphasis on new ‘higher value’ market 
opportunities, involving more technically sophisticated and innovative products. 
 
Australia is no stranger to this situation. This paper presents one example of how Australia’s 
textile industry is dealing with the transition from being a producer of traditional commodity 
type textiles to that of niche, high value, special performance textile manufacturing. This 
discusses the market for medical textiles, now emerging as one of the major growth 
opportunities for the textile industry.   
 
The Australian Textile Industry Profile    
 
To place this transformation into context, the following table sets out the magnitude of 
changes in production of ‘traditional’ textiles which have occurred in Australia over the past 
decade. 
 
Australian Textile Manufacturing Production 1999/2000 to 2005/06: 
 
 
Product 
 
1999/2000 
 
2005/06 
 
1999-2000/2005-06 
% Change 
Scoured & carbo wool                                             (kt) 118.6 53.3 -55.0% 
Wool & Man-made fibre tops                                   (kt) 55.3 4.6 -91.7% 
Wool yarn                                                                (kt) 19 8.1 -57.4% 
Cotton yarn                                                              (kt) 33.4 Not 
Published 
 
Wool fabric                                                       (‘000 sq m) 5,427 1,362 -74.9% 
Cotton fabric                                                     (‘000 sq m) 47,230 8,046 -83.0% 
Polyester/blended fabrics < 85% man-made    (‘000 sq m) 32,462 6,360 -80.4% 
Polyester/blended fabrics > 85% man-made    (‘000 sq m) 10,428 5,391 -48.3% 
Other Man-made fabrics                                   (‘000 sq m) 90,876 4,827 -94.7% 
Total woven fabrics                                           (‘000 sq m) 186,424 25,986 -86.1% 
Knitted fabrics                                                          (kt) 14.1 5.2 -63.1% 
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However, this decline in traditional textile manufacturing should not have come as a surprise 
to the Australian textile sector. A Werner International report to an Australian TCF&L Market 
Access Study in 20031 noted the following in assessing Australia’s future trade prospects in 
the field of traditional textile and garment manufacturing; 
 
‘It is clear that no developed economy, even countries that have been consolidating 
their position in the international market….can escape the contraction in local textile 
and garment production. Further trade liberalization will only accelerate the decline of 
local apparel production. Australia is no exception to this‘. 
 
Australia has experienced the full impact of changes in its textile trade following dismantling of 
most of its border protection measures over a decade ago. This has resulted in major 
rationalisation and with it, many mill closures. It should be noted that not all of the blame for 
the demise of these firms should be sheeted home to the more open market access policies 
of government. Many textile companies extracted large profits behind high levels of protection 
established after the Second World War and which continued into the 60’s and 70’s. 
Unfortunately, few firms saw the need to improve their competitive performance and increase 
focus on the development of new products. This resulted in only relatively small proportions of 
company profits being invested in new technology, R&D and skills development.  
 
Once the comfort afforded by market protection was removed, it was no surprise that many of 
these textile firms didn’t survive.  
 
Australia’s changing textile landscape 
 
It would be reasonable to conclude on the basis of the figures presented above that 
Australia’s textile industry has all but disappeared. The reality is however, somewhat different. 
There is now a growing shift towards technical textiles, industrial textiles, special performance 
textile products and generally, more technology intensive textile manufacturing.  
 
Large integrated manufacturing operations, particularly those which previously focused on 
commodity textiles have all but disappeared in the face of a surge in imports from low cost 
manufacturing countries such as China and India. Low labour cost countries now account for 
over 50% of Australia’s textile and clothing market.  
 
The Australian textile industry has responded to this increased competition with an increasing 
focus on smaller, more flexible, design and technology driven companies. These companies 
are behind the emergence of a ‘new’ textile industry, with an emphasis on higher value, 
innovative products and processes. However, these developments are also demanding new 
and higher level technical skills and knowledge. This is leading to much closer collaboration 
between research, education and industry organisations.  
 
It is in this area that the International Fibre Centre plays a role. Established in 1998 by the 
Victorian State Government (recognizing the State’s position as the major centre for textile 
manufacturing in Australia), the IFC assists technology transfer, education and skills 
development in the fibre and textile industries. As part of this role, the IFC has worked closely 
with the Centre for Material and Fibre Innovation at Deakin University’s Geelong Technology 
Precinct. IFC commissioned the Centre to undertake research into new areas of potential 
market opportunity for textiles, including nanotechnology in fibres and textiles, functional and 
smart textiles and medical applications for textiles. The international market for innovative 
products based on these technologies is estimated at billions of dollars and is expected to 
grow rapidly in future. 
 
The following case study focusing on medical textiles represents one of those areas of market 
opportunity.  
 
 
 
                                                    
1 Werner International report to the TCF&L Market Access Study in 2003 p9 
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Medical Applications of Fibres and Textiles 
 
The term medical textiles has been defined by Fisher (2006) as ‘fibre-based products and 
structures used in first aid or the clinical treatment of a wound or medical condition’. 
Applications include: protective and health care textiles, such as surgical gowns; external 
devices, such as wound dressings and orthopaedic bandages; implantable materials, such as 
surgical sutures and vascular grafts; extracorporeal devices, including blood filters and 
artificial kidneys; and dental products, such as toothbrush filaments  
Hygiene textiles, on the other hand, are described by Fisher (2006) as those that ‘deal with 
the absorption of bodily waste products, specifically urine, faeces and menstrual discharge’. 
These include nonwovens for use in disposable baby diapers, feminine hygiene products and 
adult incontinence products. Fisher makes the further point that medical textiles and 
disposable hygiene products are produced in different sectors of the industry, with the majority 
of companies manufacturing one class of product or the other. 
Notwithstanding this distinction between medical and hygiene textiles, the Medtech 
application area of technical textiles, as defined by David Rigby Associates (2000), 
encompasses all textile materials (including consumer products) used in health and hygiene 
applications. It is this broader definition of medical textiles which is generally used (unless 
indicated otherwise) throughout this paper. Both natural and man-made fibres are used to 
manufacture medical textiles, and fibre selection depends on the particular end-use properties 
required. 
Fisher (2006) reports that the global healthcare market is experiencing buoyant growth, with 
strong, long-term demand for health-related products and services. Global demand will 
continue to rise as populations increase in developing countries, and as populations age in 
developed countries. Fisher believes that the medical/hygiene textiles sector is a niche 
market dominated by a small number of large suppliers, and as such should be viewed as a 
component of the healthcare industry, rather than as an inherent part of the textile sector. 
The global healthcare market 
Healthcare is now one of the world’s largest industries, with an estimated value of US$3.5–4 
trillion per year. Global demand for healthcare services is rapidly rising as populations 
increase in developing countries, and as populations age in developed countries. In 2004, the 
world market for medical consumer goods was valued at US$220 million. The US 
dominates this market with sales of US$95 billion, followed by Europe with sales of US$65 
billion. The global market for hygiene products is valued at approximately US$73 million 
(manufacturing costs, not retail value); with 33% of this in North America, and 30% in Europe. 
This industry is based largely on oil-based by-products, where both price and demand are 
highly volatile (Fisher 2006). 
Fibres and manufacturing methods 
Fibres used in medical applications have been classified by Rigby and Anand (2000) as 
natural or synthetic, and biodegradable or non-biodegradable: ‘It is critical that these fibres 
are non-toxic, non-allergenic and non-carcinogenic, and that they can be sterilised without 
altering physical or chemical properties.’ 
Natural fibres such as cotton, silk and regenerated cellulose (e.g. viscose rayon) are widely 
used in non-implantable materials and healthcare/hygiene products (Rigby & Anand 2000). 
Commonly used synthetic materials include polyester, polyamide, polytetrafluoroethylene 
(PTFE), polypropylene, carbon and glass. Biodegradable fibres include cotton, viscose rayon, 
polyamide, polyurethane, collagen and alginate, and are absorbed by the body within two to 
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three months after implantation. Non-biodegradable fibres include polyester, polypropylene, 
PTFE and carbon, and these take more than six months to be broken down by the body. 
The following natural polymers (Rigby & Anand 2000) are important materials for wound 
dressings: 
• Collagen: obtained from bovine skin 
• Alginate: produced from seaweed 
• Chitin: obtained from crab and shrimp shells 
• Chitosan: produced from treatment of chitin with alkali. 
Collagen fibres are used as sutures, and are as strong as silk. Dressings containing calcium 
alginate fibres are haemostatic (i.e. stop bleeding) and are effective in the treatment of a wide 
variety of wounds. Chitin possesses antithrombogenic characteristics (i.e. inhibits the 
formation or development of blood clots). Chitin non-woven fabrics are used as artificial skin 
to facilitate the healing process. Synthetic fibres with important medical applications include 
polycaprolactone (PCL) and polypropiolactone (PPL). Man-made fibres based on lactic acid 
have similar strength and heat properties to nylon, and are also biodegradable. Microbiocidal 
compositions that inhibit the growth of micro-organisms can be applied as coatings natural 
fibres, or can be incorporated directly into synthetic fibres. 
Fisher (2006) has classified the manufacturing processes used for medical and hygiene 
textiles as follows: 
• Extruded polymers: used as filaments or tapes (or further processed) 
• Braided textiles: sutures; replace tendons and ligaments 
• Wovens and knitteds: bandages, vascular grafts, hernia meshes 
• Hollow fibres: blood filters 
• Nonwovens: wound dressings, disposable hygiene products, protective clothing. 
Nonimplantable materials [Rigby and Anand (2000)] 
Rigby and Anand (2000) have defined nonimplantable materials as those materials that are 
‘are used for external applications on the body and may or may not make contact with skin’. 
Table 1 illustrates the range of textile materials employed within this category, the fibres used, 
and the principal method of manufacture. 
Wound dressings are to provide protection against infection, absorb blood and exudate, 
promote healing and, in some instances, apply medication to the wound.  Generally 
composite materials are used: an absorbent layer is held between a wound contact layer and 
a flexible base material. The absorbent pad absorbs blood or liquids and protects the wound. 
The wound contact layer should prevent adherence of the dressing to the wound and be 
easily removed without disturbing new tissue growth. Base materials are normally coated with 
an acrylic adhesive to provide the means by which the dressing is applied to the wound. The 
use of natural fibres can contribute significantly to the healing process.  
Other textile materials used for wound dressing applications include gauze, lint, and wadding. 
Gauze is an open weave, absorbent fabric that when coated with paraffin wax is used for the 
treatment of burns and scalds. In surgical applications gauze serves as an absorbent material 
when used in pad form (swabs); yarns containing barium sulphate are incorporated so that 
the swab is X-ray detectable. Lint is a plain weave cotton fabric that is used as a protective 
dressing for first-aid and mild burn applications. Wadding is a highly absorbent material that is 
covered with a nonwoven fabric to prevent wound adhesion or fibre loss. 
 5
Nanofibre structures are ideal for wound dressings, due to their: large surface areas; 
controlled pore-size; controlled wettability; controlled swelling; and controlled absorption (by 
the body) (Růžičková 2006). 
Bandages 
Bandages are designed to perform a whole variety of specific functions depending upon the 
final medical requirement. They can be woven, knitted or nonwoven, and are either elastic or 
non-elastic. The most common application for bandages is to hold dressings in place over 
wounds. Such bandages include lightweight knitted or simple open weave fabrics made from 
cotton or viscose that are cut into strips then scoured, bleached and sterilised. Elasticated 
yarns are incorporated into the fabric structure to impart support and conforming 
characteristics.  
Knitted bandages can be produced in tubular form in varying diameters on either warp or weft 
knitting machines. Woven light support bandages are used in the management of sprains or 
strains and the elasticated properties are obtained using cotton crepe yarns. Similar 
properties can also be achieved by weaving two warps together, one beam under a normal 
tension and the other under a high tension. When applied under sufficient tension, the stretch 
and recovery properties of the bandage provide support for the sprained limb.  
Compression bandages are used for the treatment and prevention of deep vein thrombosis, 
leg ulceration and varicose veins, and are designed to exert a required amount of 
compression on the leg when applied at a constant tension. Compression bandages are 
classified by the amount of compression they can exert at the ankle and include extra-high, 
high, moderate and light compression, and can be either woven and contain cotton and 
elastomeric yarns or warp and weft knitted in both tubular or fully fashioned forms.  
Orthopaedic cushion bandages are used under plaster casts and compression bandages to 
provide padding and prevent discomfort. Nonwoven orthopaedic cushion bandages may be 
produced from polyurethane foams, polyester or polypropylene fibres, and contain natural or 
other synthetic fibres. Nonwoven bandages are lightly needle-punched to maintain bulk and 
loft. 
Extracorporeal devices 
Extracorporeal devices are mechanical organs that are used for blood purification and include 
the artificial kidney (dialyser), artificial liver and mechanical lung (Rigby & Anand 2000). The 
functions of these devices, and the fibres involved, are given in Table 1. 
Table 1  Extracorporeal devices 
Product 
application 
Fibre type Function 
Artificial kidney Hollow viscose, hollow polyester Remove waste products from 
patient’s blood. 
Artificial liver Hollow viscose Separate and dispose patient’s 
plasma, and supply fresh plasma. 
Mechanical 
lung 
Hollow polypropylene, hollow 
silicone, silicone membrane 
Remove carbon dioxide from 
patient’s blood, and supply fresh 
blood. 
 
(Rigby & Anand 2000, p. 417) 
The application of an artificial kidney is often referred to as hemodialysis (The Kidney 
Transplant/Dialysis Association n.d.). The most common artificial kidney is the hollow fibre 
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dialyser, a cylinder containing a bundle of thousands of tiny, hollow, cellophane-like fibres 
through which a patient’s blood passes in one direction. Dialysate circulates around and 
between the fibres. 
Cellophane is a sheet-like material made from regenerated cellulose (Kidney 
Transplant/Dialysis Association n.d.). It is semipermeable membrane, which contains 
microscopic holes or pores through which particles of only small molecular size may pass. 
Normal blood is made up of: 
• water (90%) 
• red and white cells 
• protein, fat, sugar and minerals (called electrolytes, such as sodium, potassium, calcium, 
magnesium chloride, bicarbonate and phosphate) 
• waste products (such as urea, creatinine and uric acid). 
During dialysis, waste products pass through the membrane into the dialysate, which is 
refreshed either periodically or constantly; this keeps the concentration of waste products in 
the dialysate low, and effects their permanent removal from the blood. The red and white 
cells, as well as the fat and protein molecules, are too large to pass through the membrane. 
Electrolytes (as well as water)—because of their small molecular size—are able to pass freely 
in both directions through the membrane. The concentration of the various electrolytes in 
blood must be maintained within narrow limits, and it is critical to adjust the concentrations of 
electrolytes in the dialysate to the same levels in normal human blood serum so that there is 
no net flow in either direction. 
Implantable materials (I) 
Implantable products range from sutures to vascular grafts and artificial ligaments. Key issues 
(Rigby & Anand 2000) for implants are as follows: 
• Biocompatibility: This is major importance to ensure that the material is not rejected by 
the body. 
• Porosity: This determines the rate at which human tissue will grow and encapsulate the 
implant. 
• Small circular fibres are better encapsulated with human tissue than larger fibres with 
irregular cross-sections. 
• Toxic substances must not be released by the fibre polymer, and the fibres should be 
free from surface contaminants such as lubricants and sizing agents. 
• Biodegradability. Polyamide is the most reactive material, losing its overall strength after 
only two years. PTFE is the least reactive material. 
Sutures for wound closure are manufactured from monofilament or multifilament threads 
(Rigby & Anand 2000). Biodegradable sutures are used mainly for internal wound closures, 
and non biodegradable sutures are used in situations where they can be removed when the 
wound is healed sufficiently.  
Tying of knots in conventional sutures leads to stress concentration at the knot, resulting in 
tissue distortion and inflammation. Ingle and King (2006) have developed a technique for 
producing barbed sutures (Figure 1), and these have been found to produce minimal scarring 
after cosmetic surgery.  
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Figure 1 Barbed suture, produced using razor cuts made in twisted monofilament (PG 
Cookson, Deakin University) 
The strength and flexibility textile materials make them suitable for soft-tissue implants for 
the replacement of tendons, ligaments and cartilage in both reconstructive and corrective 
surgery (Rigby & Anand 2000).  
Artificial tendons are woven or braided porous meshes or tapes surrounded by a silicone 
sheath. Braided polyester artificial ligaments are strong and exhibit resistance to creep from 
cyclic loads. Braided composite materials containing carbon and polyester filaments have also 
been found to be particularly suitable for knee ligament replacement. Low density 
polyethylene resembles natural cartilage, and is used to replace facial, nose, ear and throat 
cartilage. Carbon fibre-reinforced composite structures are used to resurface the defective 
areas of articular cartilage within synovial joints (e.g. the knee) as a result of osteoarthritis. 
Orthopaedic implants are used for hard tissue applications to replace bones and joints 
(Rigby & Anand 2000). Fibre-reinforced composite materials are replacing metal implants for 
this purpose. Nonwoven mats, which acts as an interface between the implant and the 
adjacent tissue, are used to promote tissue ingrowth. Braided surgical cables composed of 
steel filaments ranging from 13–130 microns are used to stabilise fractured bones or to 
secure orthopaedic implants to the skeleton. 
Vascular grafts, manufactured using polyester of PTFE woven or knitted structures, are used 
in surgery to replace damaged thick arteries or veins (Figure 2 (Rigby & Anand 2000). Straight 
or branched grafts are possible by using either weft or warp knitting technology. Polyester 
vascular grafts can be heat set into a crimped configuration that improves the handling 
characteristics. During implantation, the surgeon can bend and adjust the length of the graft, 
which, owing to the crimp, allows the graft to retain its circular cross-section. Knitted vascular 
grafts have a porous structure that allows the graft to become encapsulated with new tissue 
but the porosity can be disadvantageous since blood leakage (haemorrhage) can occur 
through the interstices directly after implantation. This effect can be reduced by using woven 
grafts, but the lower porosity of these grafts hinders tissue ingrowth. In addition, woven grafts 
tend to be stiffer than knitted ‘equivalents’. 
The cardiac support device shown in Figure 3 is a mesh sack manufactured from warped 
knitted polyester. It is used to prevent enlargement of the heart for patients with degenerative 
heart failure. 
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Figure 2 Vascular prosthesis (Photo by X Wang, Deakin University; vascular 
prosthesis by Boston Scientific Corporation 2006) 
 
Figure 3 Cardiac support device (Photo by X Wang, Deakin University; cardiac 
support device by Acorn Cardiovascular, Inc. 2006) 
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Implantable materials (II) – scaffold for tissue engineering 
According to Ramakrishna (2001), the profound diﬀerences between synthetic biomaterial 
implants and the living tissues of the human body can lead to problems such as infection, 
loosening, failure and finally rejection. On the other hand, transplantation (transfer of a tissue 
from one body to another, or from one location in a body to another) is not always practical 
due to a shortage of donor tissue, as well as the risk of rejection and disease transfer. Hence, 
there is a need to develop biological substitutes (living or vital materials) to avoid these 
problems.  
Tissue engineering ‘combines mammalian cells and certain synthetic biodegradable 
materials (materials that eventually disappear after being introduced into a living tissue or 
organism) to produce living (vital) synthetic tissue substitutes or replacement tissues’ 
(Ramakrishna 2001).  
It is envisaged that tissue substitutes will merge seamlessly with the surrounding host tissue, 
eliminating problems associated with contemporary biomaterials and transplantation. 
Considerable research is being carried out globally to produce engineered skin, cartilage, 
nerve, heart valve and blood vessels. Eventually, it may even be possible to construct entire 
replacement organs such as the liver and bladder. 
Some of the major features of an ideal scaffold system (Ramakrishna 2001) are:  
• The material used for the scaffold should be: (i) biocompatible; (ii) ultra-pure; and (iii) 
able to formed reproducibly—at both the microscopic and macroscopic levels—into a 
variety of sizes and structures.  
• The scaffold needs to be manufactured from biodegradable material that maintains its 
volume, structure and mechanical stability long enough to allow adequate formation of 
tissue inside the scaffold. None of the degradation products should lead to inflammation 
or toxicity.  
• In order to facilitate cell-surface interaction, scaffolds must: (i) have a high surface-area 
to volume ratio; (ii) have controlled interconnected pore structures, pore size distribution 
and pore geometry; and (iii) be able to retain their shape and structure under electro-
mechanical conditions. 
• The flexibility of a scaffold should be close to that of its surrounding tissue, so that once 
vascularisation starts, no extreme change in the mechanical properties between the host 
tissue and the scaffold will be experienced by the ingrowing tissue. 
A combination of various factors, including: (i) scaffold material; (ii) structure; (iii) physical, 
chemical (especially surface), mechanical and biological properties; (iv) cell types; and (v) in 
vitro or in vivo conditions, determine the success of tissue engineering.  
The different scaffold materials used in tissue engineering can be grouped into natural and 
synthetic materials. Collagen, chitin and starch are examples of natural materials that are 
isolated from human, animal or plant tissues; they typically result in high costs and large 
batch-to-batch variations, exhibit a very limited range of properties and are often difficult to 
process.  
Synthetic materials are classified as degradable or non-degradable types. Non-degradable 
materials include polyethylene, polyethyleneterephthalate and PTFE. Synthetic biodegradable 
polymers, such as PGA and PLA, polyanhydrides and polyorthoesters offer control over 
structure and properties, as well as degradation times, and have been widely investigated in 
tissue engineering research. Polyester-based materials dominate the tissue engineering 
applications of the biodegradable polymers.  
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Cells are totally dependent on some sort of substrate for their proliferation. There is no 
universal textile scaffold that meets all the requirements of various tissues. The optimum 
design of a scaffold for a specific tissue application requires consideration of microstructural, 
chemical and biological aspects, which are often difficult to isolate as they are interdependent 
and sometimes have unknown effects.  
The microstructural aspects of scaffolds include the size and size distribution, porosity and 
connectivity of the pores. These aspects provide the optimal spatial and nutritional conditions 
for the cells, and determine the successful integration of the natural tissue and the scaffold.  
The size and alignment of pores in a scaffold has been shown to have a large influence on 
the amount and rate of vascular and connective tissue growth. The interconnectivity of pores 
determines the transport of nutrients and waste. The reproducibility of scaffolds is also very 
important as it determines the dimensional stability of the scaffold as well as the consistency 
of the tissue formation. 
The mechanical aspects of scaffolds, such as structural stability, stiffness and strength, have 
considerable influence on cellular activity. Cell shape modification takes place as a result of 
forces both external (including gravity) and internal, and is influenced by the nature (constant 
or cyclic), type (uniaxial, biaxial, multiaxial and so on) and magnitude of the mechanical 
stimulation. The mechanical stimulation also affects the release of soluble signalling factors 
and the deposition of extracellular matrix constituents.  
In bone tissue engineering, scaffolds are designed to withstand severe physiological loads. In 
blood vessel applications, the scaffold needs to be strong enough to withstand physiologically 
relevant pulsatile pressures and at the same time match the compliance or elasticity values of 
a native blood vessel. The mechanical aspects of various scaffolds are compared in Table 6. 
Woven fabrics are relatively rigid, and are used for engineering of bone and acetabular cups. 
Knits display considerable deformability, and are suitable for bladder and blood vessel tissue 
engineering applications 
Fibre- and textile-reinforced composites in medicine [Ellis (2005)]. 
Splinting materials for the repair of broken bones are the oldest and largest medical market 
for textile-reinforced composites. The use of textile materials overcomes brittleness problems 
associated with plaster of Paris.  
The requirements for a splinting material are a high degree of stiffness, conformability and an 
open construction to allow for impregnation with a large quantity of plaster. These 
requirements can conveniently be met by a leno woven construction where the warp yarns 
cross over one another, locking the weft into place (Figure 21). Such a fabric is also less 
inclined to fray when cut. 
Similar characteristics can also be obtained with various warp knitted and some weft knitted 
constructions. A number of fibres have been used in conjunction with plaster, particularly 
cotton, although modern bandages on the market contain combinations of elastomeric yarn 
and polypropylene, polypropylene, polyester and even glass. Glass has fallen into disfavour, 
particularly because of the presence of glass dust produced during cast removal.  
Walking support frames provide vertical support for patients who have dysfunctional lower 
limbs. In comparison with a metallic frame, the reductions in both weight and volume—
combined with increased rigidity—of a carbon fibre reinforced orthosis have led to marked 
improvements in walking capability. Although carbon-based materials have brittle failure 
characteristics, the mode of failure of such devices is of progressive collapse and is therefore 
inherently safe. Thermoset resin-based materials cannot readily be bent into shape to fit a 
patient, and so the use of composites in smaller orthoses (such as knee braces) is limited. 
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In orthopaedic surgery, bone plates and screws are often used to treat fractures, particularly 
of the long bones, and are generally are manufactured from stainless steel, cobalt chromium 
and titanium alloys (Figure 22). The elastic modulus of these metals is much higher than the 
elastic modulus of human bone (110–220 GPa compared with 17–24 GPa for human bone).  
Because of this stiffness mismatch, the normal bone healing process is affected. Possible 
toxic effects (particularly from unreacted monomers) of all implanted polymeric products, 
combined with the fact that thermoset bone plates cannot easily be bent to shape in the 
operating theatre, has limited the possibilities for composites. 
Healthcare/hygiene products 
Rigby and Anand (2002) have described the vast range of healthcare and hygiene products 
as typically being used ‘either in the operating theatre or on the hospital ward for the hygiene, 
care, and safety of staff and patients’. As discussed above, however, hygiene textiles—for the 
purposes of this report—also cover the consumer market, and include such items as feminine 
hygiene products and baby diapers.  
Operating room textiles include surgeons’ gowns, caps and masks, patient drapes, and 
cover cloths of various sizes. Disposable nonwoven surgical gowns have been adopted to 
prevent sources of infection being transferred to the patient from hospital staff. These 
materials often combine nonwoven materials and polymer films. For example, Ahlstrom 
market a breathable viral barrier fabric (Ahlstrom BVBTM—Figure 4) with the following 
structure: 
• trilaminate polypropylene-based composite material with a breathable film 
• outer layer provides strength and some fluid resistance 
• inner layer provides softness 
• middle layer blocks viruses and bacteria, but is permeable to moisture vapour. 
 
Figure 4 Ahlstrom (2006) display at ANEX 2006 (Photo by PG Cookson, Deakin 
University) 
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Although the primary function of operating room and hospital clothing is a one of protection, it 
is critical that they are comfortable to wear. Physiological function and wear comfort can be 
measured and assessed objectively. The Hohenstein Institute has developed physiological 
evaluation models, based on laboratory tests with a sweating Skin Model, skin sensorial 
apparatus and a thermal manikin (Umbach 2006).  
Surgical masks consist of a very fine middle layer of extra fine glass fibres or synthetic 
microfibres covered on both sides by either an acrylic bonded parallel-laid or wet-laid 
nonwoven. The application requirements of such masks demand that they have a high filter 
capacity, high level of air permeability, and are lightweight and non-allergenic. Disposable 
surgical caps are usually parallel-laid or spun-laid nonwoven materials based on cellulosic 
fibres. 
Surgical drapes and cover cloths are used in the operating theatre either to cover the patient 
(drapes) or to cover working areas around the patient (cover cloths). They are made of films 
backed on either one or both sides with nonwoven fabric. The film is impermeable to bacteria 
while the nonwoven backing is highly absorbent to both body perspiration and secretions from 
any wound. Loop-raised warp-knitted polyester fabrics—laminated with PTFE films for air 
permeability, comfort and resistance to microbiological contaminants—are used for surgical 
drapes. 
Hospital ward textiles such as bedding, clothing, mattress covers, incontinence products, 
cloths and wipes are used on hospital wards for the care and hygiene of patients. Traditional 
woollen blankets have been replaced with cotton leno woven blankets to reduce the risk of 
cross-infection—they are made from soft-spun twofold yarns which possess the desirable 
thermal qualities; they are also durable and can be easily washed and sterilised. 
Clothing products, which include articles worn by both nursing staff and patients, have no 
specific requirements other than comfort and durability and are therefore made from 
conventional fabrics. In isolation wards and intensive care units, disposable protective clothing 
is worn to minimise cross infection. These articles are made from composite fabrics consisting 
of tissue reinforced with a polyester or polypropylene spun-laid web. 
Incontinence products for patients are available in both diaper and flat sheet forms, with the 
latter used as bedding. A number of weft- and warp-knitted pile or fleece fabrics made from 
polyester are also used as part of a composite material, which includes foam as well as PVC 
sheets for use as incontinence mats.  
Cloths and wipes are made from tissue paper or nonwoven bonded fabrics, which may be 
soaked with an antiseptic finish. The cloth or wipe may be used to clean wounds or the skin 
prior to wound dressing application, or to treat rashes or burns.  
Surgical hosiery with graduated compression characteristics is used for a number of 
purposes, ranging from a light support for the limb, to the treatment of venous disorders. Knee 
and elbow caps, which are normally shaped during knitting on circular machines and may also 
contain elastomeric threads, are worn for support and compression during physically active 
sports, or for protection. 
Richer Investment Consulting Services (2006) report that there are 13 basic components to a 
baby’s diaper, and four of these are fibre/textile based:  
• Hydrophobic nonwoven: This is used as a top sheet for the leg cuffs, and prevents 
leakage to the outside of the diaper. 
• Hydrophilic nonwoven: This is the main top sheet. Its surface is in contact with the baby’s 
skin, and allows liquids to flow into the diaper core. Hydrophilicity is achieved using a 
surfactant treatment. 
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• Cellulose: Used in the construction of the pad, this gives integrity and absorbing capacity 
to the diaper. 
• Acquisition and distribution layer: A nonwoven sub layer between the top sheet and 
absorbent core. This is specially needed when the absorbent core is very thin in order to 
move liquids quickly into the absorbent core and reduce leakage. 
Diaper manufacturing machines are 20–45 metres long, 6–13 metres wide, and have 
production rates as high as 1000 pieces/minute. It is estimated that 1.4 billion baby diapers 
are used daily, and that landfill issues will endure for up to 500 years.  
Polytrimethylene terephthalate (PTT) fibre is used by Solotex in products such as toothbrush 
filaments. In comparison with PET, PTT fibre is claimed to have superior softness, durability, 
wrinkle recovery and dyeability (Solotex 2004). Whereas PET shows 29% recovery from 20% 
elongation, PTT exhibits 88% recovery. These ‘exceptional elastic characteristics’ are said to 
be due to the ‘zigzag conformation of [PPTs] crystalline structure’ (Solotex 2004). 
Medical sheepskins 
Pressure ulcers are preventable adverse events that are both common and costly. A national 
survey in the US reported a prevalence of 14.8% across 365 acute hospitals. A pressure ulcer 
of Stage 2 or higher has been calculated to increase patients’ costs by a factor of 2.7, while 
the annual cost of pressure ulcers to the American healthcare system is estimated at $US3.6 
billion (Jolley et al. 2004). 
Many types of pressure-relieving support surfaces are available, but a systematic review 
found that the only surfaces that consistently outperformed the standard hospital mattress in 
reducing the incidence of pressure ulcers were high-specification foam mattresses. However, 
the review also stated that most interventional studies of pressure-relieving support surfaces 
were seriously underpowered or had other methodological flaws. 
In the 1960s and ‘70s, sheepskins were reported to help prevent pressure ulcers, but recent 
reviews have found inconclusive evidence to support their use (Jolley et al. 2004). In 1998, 
CSIRO introduced a new high-performance medical sheepskin, the Australian Medical 
Sheepskin.  This product has a denser and higher wool pile and can withstand multiple 
washes at 80°C, representing a significant advance in leather technology. A randomised 
controlled trial found that use of this sheepskin reduced the incidence of pressure ulcers in 
297 elderly orthopaedic patients by 68% (compared with standard practice). These results 
were extrapolated to a broader hospital population, where it was found that an Australian 
Medical Sheepskin pressure-relieving support may prevent one new Stage 1 or Stage 2 ulcer 
every 46 bed-days of use in general hospital patients at low to moderate risk; these results 
apply when the sheepskin is used for prophylaxis from the time of admission.  
Health-monitoring garments 
According to Paradis, Loriga and Taccini (2004), the new generation of technological tools, in 
particular in the field of telecommunications, has taught people to be continuously in touch 
with each other. This virtual link is revolutionary in the way of feeling, and if coupled with 
innovative sensing architectures, could be revolutionary also in the way of acting. There is an 
emerging need to renovate our health management systems. People need to be more and 
more conscious of their health status, and more interactive with social assistance services. 
Remote health monitoring will be accepted and used only if the monitoring devices are based 
on wearable sensing interfaces, are easy to use, and are easily customised. 
Bateup has described the evolution of ‘intelligent textiles’ occurring in the following stages: 
1. Functional 
– protection against the environment 
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– active moisture management 
2. Smart 
– sensing and monitoring changes in the environment 
– some electrical conducting function (conducting textiles) 
3. Intelligent 
– react in some way in response to the ‘sensed’ property 
– most likely have electronic function 
(Bateup 2005, p. 4) 
Smart textiles are likely to have a significant role to play in the medical area. The LifeShirt by 
VivoMetrics (1999) has had considerable publicity. It consists of an undergarment into which 
is sewn an array of sensors that enable the monitoring, recording, analysing and interpreting 
of vital signs. This monitoring can be carried out during normal work and recreation activities.  
Photonic textiles are best described as textiles containing flexible arrays of LEDs as lighting 
systems. Applications in cushions, rugs and backpacks are anticipated. Based on this 
concept, Philips is looking at the development of a baby jaundice sleeping bag (Asvardi 
2006). This will be embedded with blue LEDs, which will break down bilirubin. 
 
Figure 39 Bilirubin breakdown (PG Cookson, Deakin University) 
The ability of a textile to mold to body shape will facilitate treatment. A low intensity light 
therapy is well suited to a treatment in the home environment. 
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